p********m
发帖数: 93 | 1 WASHINGTON (MarketWatch) -- The U.S. Securities and Exchange Commission on
Tuesday charged a U.S. Food and Drug Administration chemist with insider
trading on confidential information about announcements of FDA drug approval
decisions. The chemist, Cheng Yi Liang, traded in advance of at least 27
public announcements about FDA drug approval decisions involving 19 publicly
traded companies, the SEC alleges. The trades generated more than $3.6
million in illicit profits and avoided losses, the SEC said. | g8
发帖数: 3784 | |
|
